| For: | Feng J, Liang B, Zhang HY, Liu Z, Jiang K, Zhao XQ. Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients. World J Gastrointest Surg 2022; 14(5): 442-451 [PMID: 35734620 DOI: 10.4240/wjgs.v14.i5.442] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v14/i5/442.htm |
| Number | Citing Articles |
| 1 |
Chenxi Li, Yifei Dong, Yichuan Zhang, Caihong Wu. Clinical significance of lncRNA XIST expression in cholangiocarcinoma and its effect on cell migration and invasion. Clinics and Research in Hepatology and Gastroenterology 2024; 48(7) doi: 10.1016/j.clinre.2024.102398
|
| 2 |
Laurence Lacaze, Damien Bergeat, Chloé Rousseau, Laurent Sulpice, David Val-Laillet, Ronan Thibault, Karim Boudjema. High Visceral Fat is Associated with a Worse Survival after Liver Resection for Intrahepatic Cholangiocarcinoma. Nutrition and Cancer 2023; 75(1) doi: 10.1080/01635581.2022.2117387
|
| 3 |
Alejandra Méndez Romero, Thomas C. Zwaan, Suus Y. van Loosbroek, Jens Ricke, Bas Groot Koerkamp. The use of locoregional therapies in cholangiocarcinoma. Journal of Hepatology 2026; 85(4) doi: 10.1016/j.jhep.2026.07.012
|